For patients between the ages of 22-75 with a confirmed diagnosis of chronic locked-in syndrome
We are experiencing extremely high call volume related to COVID-19 vaccine interest. Please understand that our phone lines must be clear for urgent medical care needs. We are unable to accept phone calls to schedule COVID-19 vaccinations at this time. When this changes, we will update this web site. Please know that our vaccine supply is extremely small. Read all COVID-19 Vaccine Information.
The Johns Hopkins Department of Neurology is recruiting participants for two upcoming clinical trials. Both studies will investigate brain-computed interface (BCI) systems for patients with movement and communication impairments. Dr. Nathan Crone, professor of neurology, will lead both trials.
The Summit study will test a specific BCI, the Medtronic Summit System, for patients with chronic locked-in syndrome, a disorder in which communication is impaired by severe paralysis. The goal of the study is to assess this particular BCI's ability to assist communication.
To learn more about the Summit Study, call 410-955-6772.
Like the Summit Study above, this trial will also evaluate a specific BCI model. However, this study will test a different BCI, the CortiCom system.
The Cortical Communication (CortiCom) System's electrical grid connects to the rest of the computer system and its software.
To learn more about the CortiCom Study, call 410-955-6772.